SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001019056-24-000305
Filing Date
2024-10-29
Accepted
2024-10-29 21:46:26
Documents
4
Group Members
HOCHE PARTNERS PHARMA HOLDING S.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A procaps_13da12.htm SC 13D/A 40293
2 EXHIBIT 99.24 ex99_24.htm EX-99.24 18878
3 GRAPHIC ex99_24image001.jpg GRAPHIC 4741
4 GRAPHIC ex99_24image002.jpg GRAPHIC 5565
  Complete submission text file 0001019056-24-000305.txt   75179
Mailing Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273 575-371-9280
Procaps Group, S.A. (Subject) CIK: 0001863362 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92922 | Film No.: 241407171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3A VAL SAINTE CROIX LUXEMBOURG N4 L-1371
Business Address 3A VAL SAINTE CROIX LUXEMBOURG N4 L-1371 352 2744 7303
Hoche Partners Pharma Holding S.A. (Filed by) CIK: 0001884588 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A